Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal intraepithelial neoplasias and anogenital warts (condyloma acuminata). Design Data from two international, double blind, placebo controlled, r...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907480/
https://www.ncbi.nlm.nih.gov/pubmed/20647284
http://dx.doi.org/10.1136/bmj.c3493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907480/
https://www.ncbi.nlm.nih.gov/pubmed/20647284
http://dx.doi.org/10.1136/bmj.c3493

Ejemplares similares